FDA Brief

Warning letters Drugs

FDA warning letter to

pharmacygeoff.md

High riskIssued Apr 15, 2021Posted Apr 27, 2021Center for Drug Evaluation and Research

Website pharmacygeoff.md sells unapproved, misbranded prescription drugs, including COVID-19 claims, to U.S. consumers.

What happened

FDA reviewed the website www.pharmacygeoff.md on March 22, 2021. FDA found the site offering prescription drugs for sale to U.S. consumers, including hydroxychloroquine (Plaquenil), chloroquine (Lariago-DS), lopinavir/ritonavir (Hivus-LR, Lopimune), ribavirin (Ribasure) and dexamethasone (Dexona), with claims they treat COVID-19 and other diseases. FDA said there were no FDA-approved applications for these products as offered, and that the site did not require a prescription.

What FDA found

  1. The site sells new drugs that FDA has not approved for these uses.

    Section 505(a) of the FD&C Act [21 U.S.C. § 355(a)]
  2. The site puts unapproved drugs into interstate commerce.

    Section 301(d) of the FD&C Act [21 U.S.C. § 331(d)]
  3. The drug labeling lacks adequate directions for use, so a layperson cannot use the products safely.

    Section 502(f)(1) of the FD&C Act [21 U.S.C. § 352(f)(1)]; 21 CFR 201.5
  4. The site offers prescription drugs without requiring a prescription.

    Sections 503(b)(1) and 301(k) of the FD&C Act [21 U.S.C. § 353(b)(1), § 331(k)]

What FDA wants

FDA asks the company to stop selling the unapproved and misbranded products and, within 48 hours, email FDA the specific steps taken to fix the violations and prevent them from recurring, with supporting documents. If corrective action cannot be finished in that time, the company must explain the delay and say when it will be done.

Who should pay attention

  • online pharmacies and websites that ship prescription drugs to U.S. consumers
  • companies making COVID-19 treatment claims for unapproved products
  • makers of brand-name drugs whose names appear on such sites

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. New Green Nutrition Inc.

    FDA says New Green Nutrition sold unapproved drugs online, and its Qu Feng Huo Luo Dan contained hidden dexamethasone.

    High risk
  2. Ong Tien USA LLC

    FDA warned Ong Tien USA LLC that its herbal joint products are unapproved drugs and one contained hidden piroxicam and dexamethasone.

    High risk
  3. Jing Cheong Asia Inc. dba New York Tong Ren Tang

    New York Tong Ren Tang marketed unapproved new drugs, including eye drops, on its website.

    High risk
  4. Phuoc Loc Tho Herbals, Inc.

    FDA warned Phuoc Loc Tho Herbals that its herbal products are unapproved new drugs marketed with disease claims.

    High risk